The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics

Active, not recruitingOBSERVATIONAL
Enrollment

317

Participants

Timeline

Start Date

October 6, 2022

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2026

Conditions
Pancreatic Ductal AdenocarcinomaPancreatic CystChronic PancreatitisFatty PancreasGenetic Pancreatic CancerGenetic PancreatitisBRCA MutationLynch SyndromeFAPFamilial Atypical Multiple Mole-MelanomaPALB2 Gene MutationPeutz-Jeghers SyndromeAtaxia Telangiectasia
Interventions
OTHER

Data collection

Investigators will compile data typically collected clinically. This data will include demographics, cancer screening procedures, cancer diagnosis and staging, chemotherapy, immunotherapy, radiation therapy, surgery, comorbidities, medication use, lifestyle and other cancer risk factors, quality of life, vital status, and molecular data generated from specimens collected clinically.

Trial Locations (1)

33617

Moffitt Cancer Center, Tampa

All Listed Sponsors
lead

H. Lee Moffitt Cancer Center and Research Institute

OTHER